Health

Alibaba and Ping An-backed Prenetics is set to complete a reverse merger at a $1.25bn valuation. Exits from the broader genetics and gene therapeutics space appear to be in the middle of a valuation spike, according to our data.

Conductive Ventures returned for online savings platform developer Self Financial's $50m series E round while EV producer Volta Trucks completed its $43.6m series B.

Digital mental health platform Spring Health was valued at $2bn through a series C round backed by strategic investor Guardian Life.

The endocrine disease treatment developer pushed its overall funding past $160m in a round featuring Novo, Sham and Mass General Brigham.

Genetic testing services provider Prenetics, a spinout of City University of Hong Kong, will hold a reverse merger at a $1.25bn valuation.

Immutable, Abra and Francis Medical have all raised more than $50m, while MAZ Systems has been acquired by Zype.

Alibaba and Ping An-backed genetic testing services provider Prenetics will hold a reverse merger at a $1.25bn valuation, securing $120m in Pipe financing.

Sanofi Ventures, Mass General Brigham Ventures, GV and Alexandria Venture Investments have contributed to a $77m round for Rome Therapeutics.

Online furniture retailer Gaia, warehouse robot provider Locus Robotics, recruitment platform developer Canvas and ESG software producer Measurabl all raised $50m.

Every day, Global University Venturing rounds up the smaller investments from across the university innovation ecosystem in its deal net.

Based on research at Drexel University, Context Therapeutics is seeking to raise up to $21m in an initial public offering on Nasdaq.